Cargando…
The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors
The landscape of CDC20 gene expression and its biological impacts across different types of cancers remains largely unknown. Here, a pan-cancer analysis was performed to analyze the role of Cdc20 in various human cancers. Our results indicated that the expression levels of the CDC20 gene were signif...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435897/ https://www.ncbi.nlm.nih.gov/pubmed/34527589 http://dx.doi.org/10.3389/fonc.2021.721797 |
_version_ | 1783751900593651712 |
---|---|
author | Wu, Fei Sun, Yang Chen, Jie Li, Hongyun Yao, Kang Liu, Yongjun Liu, Qingyong Lu, Jiaju |
author_facet | Wu, Fei Sun, Yang Chen, Jie Li, Hongyun Yao, Kang Liu, Yongjun Liu, Qingyong Lu, Jiaju |
author_sort | Wu, Fei |
collection | PubMed |
description | The landscape of CDC20 gene expression and its biological impacts across different types of cancers remains largely unknown. Here, a pan-cancer analysis was performed to analyze the role of Cdc20 in various human cancers. Our results indicated that the expression levels of the CDC20 gene were significantly elevated in bladder cancer, breast cancer, colon cancer, rectum cancer, stomach cancer, esophageal cancer, head and neck cancer, kidney cancer, liver cancer, lung cancer, prostate cancer, pancreatic cancer, and uterine cancer. In addition, the expression of CDC20 was significantly and positively correlated with the increase of clinical stages in multiple cancer types, including breast cancer, kidney cancer, and lung cancer, et al. Among 33 cancer subtypes in the TCGA dataset, the high expression of CDC20 was correlated with poor prognosis in 10 cancer types. Furthermore, the abundance of phosphorylated Cdc20 in the primary tumor was elevated and correlated with increased tumor grade. Next, we sought to elucidate the oncogenic role by analyzing its association with immune infiltration. For most cancer types, the CDC20 expression was positively correlated with the infiltration of cancer-associated fibroblasts and myeloid-derived suppressor cells. To further understand its functional activity, we explored the classic Cdc20 downstream substrates, which were found to be mutually exclusive with the expression of Cdc20. Moreover, the pan-cancer analysis of the molecular function of Cdc20 indicated that BUB1, CCNA2, CCNB1, CDK1, MAD2L1, and PLK1 might play a critical role in interaction with Cdc20. The abundance of Cdc20 was further validated at transcriptional and translational levels with a publicly available dataset and clinical tumor tissues. The knockdown of Cdc20 dramatically inhibited tumor growth both in vivo and in vitro. Therefore, our studies delineated the oncogenic role of CDC20 and its prognostic significance at the pan-cancer level and proved its functional activity in Cdc20 high expression cancer types. Our studies will merits further molecular assays to understand the potential role of Cdc20 in tumorigenesis and provide the rationale for developing novel therapeutic strategies. |
format | Online Article Text |
id | pubmed-8435897 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84358972021-09-14 The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors Wu, Fei Sun, Yang Chen, Jie Li, Hongyun Yao, Kang Liu, Yongjun Liu, Qingyong Lu, Jiaju Front Oncol Oncology The landscape of CDC20 gene expression and its biological impacts across different types of cancers remains largely unknown. Here, a pan-cancer analysis was performed to analyze the role of Cdc20 in various human cancers. Our results indicated that the expression levels of the CDC20 gene were significantly elevated in bladder cancer, breast cancer, colon cancer, rectum cancer, stomach cancer, esophageal cancer, head and neck cancer, kidney cancer, liver cancer, lung cancer, prostate cancer, pancreatic cancer, and uterine cancer. In addition, the expression of CDC20 was significantly and positively correlated with the increase of clinical stages in multiple cancer types, including breast cancer, kidney cancer, and lung cancer, et al. Among 33 cancer subtypes in the TCGA dataset, the high expression of CDC20 was correlated with poor prognosis in 10 cancer types. Furthermore, the abundance of phosphorylated Cdc20 in the primary tumor was elevated and correlated with increased tumor grade. Next, we sought to elucidate the oncogenic role by analyzing its association with immune infiltration. For most cancer types, the CDC20 expression was positively correlated with the infiltration of cancer-associated fibroblasts and myeloid-derived suppressor cells. To further understand its functional activity, we explored the classic Cdc20 downstream substrates, which were found to be mutually exclusive with the expression of Cdc20. Moreover, the pan-cancer analysis of the molecular function of Cdc20 indicated that BUB1, CCNA2, CCNB1, CDK1, MAD2L1, and PLK1 might play a critical role in interaction with Cdc20. The abundance of Cdc20 was further validated at transcriptional and translational levels with a publicly available dataset and clinical tumor tissues. The knockdown of Cdc20 dramatically inhibited tumor growth both in vivo and in vitro. Therefore, our studies delineated the oncogenic role of CDC20 and its prognostic significance at the pan-cancer level and proved its functional activity in Cdc20 high expression cancer types. Our studies will merits further molecular assays to understand the potential role of Cdc20 in tumorigenesis and provide the rationale for developing novel therapeutic strategies. Frontiers Media S.A. 2021-08-30 /pmc/articles/PMC8435897/ /pubmed/34527589 http://dx.doi.org/10.3389/fonc.2021.721797 Text en Copyright © 2021 Wu, Sun, Chen, Li, Yao, Liu, Liu and Lu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Wu, Fei Sun, Yang Chen, Jie Li, Hongyun Yao, Kang Liu, Yongjun Liu, Qingyong Lu, Jiaju The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors |
title | The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors |
title_full | The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors |
title_fullStr | The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors |
title_full_unstemmed | The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors |
title_short | The Oncogenic Role of APC/C Activator Protein Cdc20 by an Integrated Pan-Cancer Analysis in Human Tumors |
title_sort | oncogenic role of apc/c activator protein cdc20 by an integrated pan-cancer analysis in human tumors |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435897/ https://www.ncbi.nlm.nih.gov/pubmed/34527589 http://dx.doi.org/10.3389/fonc.2021.721797 |
work_keys_str_mv | AT wufei theoncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT sunyang theoncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT chenjie theoncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT lihongyun theoncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT yaokang theoncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT liuyongjun theoncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT liuqingyong theoncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT lujiaju theoncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT wufei oncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT sunyang oncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT chenjie oncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT lihongyun oncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT yaokang oncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT liuyongjun oncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT liuqingyong oncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors AT lujiaju oncogenicroleofapccactivatorproteincdc20byanintegratedpancanceranalysisinhumantumors |